glp 1 receptor agonists effects on cardiovascular risk reduction Complementary Yet Distinct Roles of GLP-1 and SGLT2 Inhibitors in Glucagon-like peptide-1 receptor agonists' impact

Popular drugs credited with shrinking waistlines and controlling blood sugar may also take the edge off alcohols buzz, according to a new study

GLP-1 (glucagon-like peptide-1) helps regulate blood sugar, reduce appetite, and increase feelings of fullness, making it easier for patients to manage their weight

all authors revised and edited the manuscript

Several large-scale clinical trials and post-marketing surveillance studies have reported higher rates of cholelithiasis (gallstones) and cholecystitis (gallbladder inflammation) among patients treated with GLP-1 agonists compared to placebo or other glucose-lowering medications

Review how semaglutide weight loss or tirzepatide weight loss dosing is adjusted over time